Hua Xiang

2 ta ish

China Pharmaceutical University

1. Novel SERMs based on 3-aryl-4-aryloxy-2H-chromen-2-one skeleton - A possible way to dual ERα/VEGFR-2 ligands for treatment of breast cancer

   Guoshun Luo, Xinyu Li, Guoqing Zhang +5

   Maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.072990

2. Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance

   Xin Lin, Hua Xiang, Guoshun Luo

   Sharh maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.316038